We have a similar system, in terms of the fact that there are systems in place to ensure that we don't have that black market you are talking about. We are moving forward with looking at or exploring avenues where we can put in strategies that are going to minimize the kind of personal use importation you might be talking about, getting drugs through the black market. We are looking at those strategies.
Again, we have a task force that was struck about a year ago, in 2007, that is clearly looking at personal use importation, the fact that there are certainly potential health and safety concerns about products that may be coming from China and India via the U.S. or other countries that may pose a risk to humans. We are looking at those strategies.